CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 15 enrolled
Drug / intervention
Ropivacaine Hcl 0.5% Inj Vil 20Mldrug
Likely dose
Ropivacaine Hcl 0.5% Inj Vil 20Mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03746951
NCT03746951Phase 3Completed
CompareCT.gov

Comparative Evaluation of Lumbar Plexus and Suprainguinal Fascia Iliaca Compartment Blocks for Pain Management After Orthopedic Surgical Procedures Involving Hip and Femur in Pediatrics.

Nationwide Children's Hospital·interventional·Posted Nov 20, 2018·Updated Mar 3, 2022

In Brief

A Phase 3 clinical trial evaluating Ropivacaine Hcl 0.5% Inj Vil 20Ml for Orthopedic Disorder. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The investigators aim to compare the use of a suprainguinal fascia iliaca compartment block vs lumbar plexus block as an adjunct to general anesthesia in pediatric patients undergoing orthopedic procedures involving the hip or upper femur. This study will help determine the efficacy of the two techniques and their advantages when compared to each other including time to perform the block, opioid consumption reduction, effects on postoperative pain, and the length of stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOrthopedic Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedNov 20, 2018
Enrollment StartApr 24, 2019
Primary CompletionJan 31, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.6 years ago

Interventions

Ropivacaine Hcl 0.5% Inj Vil 20Mldrug

Anesthetic agent used in peripheral nerve block